![]() |
|
|
Forward to a colleague |
||
Product Presentation ![]() CyBio has introduced an innovative enhancement in simultaneous pipetting, two new exchangeable modules for Nanoliter parallel pipetting further extending the broad range of applications of the proven CyBio®:-Well vario pipetting platform... Click Here Access Full Stories Isis Pharmaceuticals has initiated a Phase I safety study for its first-in-class antisense drug that aims to control blood glucose levels in patients with Type II diabetes... Read IonGate and LIVC to push screening to the next level High-throughput (HT) screening expert IonGate will assist start-up LIVC with the development and marketing of its novel light-activated ion channel switching technology... Read AstraZeneca increases affinity for China AstraZeneca's affinity for China continues to escalate as the firm announced its first clinical pharmacology investment in the country... Read Serenex turns drug discovery back to front Serenex is turning the world of drug discovery inside out by first finding an effective drug candidate and then working out what its target is... Read Millipore targets arthritis research efficiency Millipore has released a new kit that allows researchers to quickly generate arthritis mouse models for screening and evaluating anti-inflammatory therapeutics... Read |
||||||||||
All News Headlines for: September | August | July |
||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Tata bags major BPO deal with Roche Indian IT firm Tata Consultancy Services (TCS) has bagged its second high profile pharma outsourcing deal this year with a new multi-year contract with Swiss drug maker Roche... Read Acambis gets smallpox vaccine approval Acambis has had its smallpox vaccine approved by the US, coming one step closer to closing another supply contract for the US Strategic National Stockpile... Read Abbott and AstraZeneca combine cholesterol drugs Abbott and AstraZeneca are the latest pharmaceutical companies to take on the $21.6bn (€15.8bn) cholesterol market with a combination drug... Read Does using a CRO reduce site profits? Are profits for clinical investigative sites reduced by the presence of a contract research organisation (CRO)?... Read
|
||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||